Adhera Therapeutics, Inc. Debt Conversion, Converted Instrument, Rate
Adhera Therapeutics, Inc. reported Debt Conversion, Converted Instrument, Rate of 60.00% for the 0-month period ending 2020-05-05, per its 10-K filed 2021-04-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentRate · last filed 2021-04-07
- 2020-05-05: Debt Conversion, Converted Instrument, Rate 0 month 60.00%; Debt Conversion, Converted Instrument, Rate 60.00%.
| Period end | Debt Conversion, Converted Instrument, Rate 0 month | Debt Conversion, Converted Instrument, Rate |
|---|---|---|
| 2020-05-05 | 60.00% 10-K · filed 2021-04-07 | 60.00% 10-Q · filed 2020-08-19 |